The Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies today held a hearing on the Department of Health and Human Services’ funding request for fiscal year 2019. Chairman Roy Blunt (R-MO) expressed concern that the department’s proposal would eliminate funding for the Children’s Hospitals Graduate Medical Education program and the majority of health workforce training programs, among other priorities. “While I understand difficult choices had to be made, I believe it’s unlikely this subcommittee will support these eliminations.” Ranking Member Patty Murray (D-WA) said, “I want to make clear today that we will vigorously oppose any effort to undo the bipartisan deal the president signed into law.” Among hospital-specific comments, Sens. James Lankford (R-OK) and Brian Schatz (D-HI) emphasized the importance of adequate reimbursement and telehealth to rural hospitals, and Sen. Jerry Moran (R-KS) highlighted the importance of the 340B drug savings program to vulnerable hospitals and patients. Committee members also noted the effect the opioid epidemic has had on their states and expressed concern with rising drug prices. The president is expected to make a speech tomorrow afternoon outlining steps the administration will take to address drug pricing.

Related News Articles

Headline
The Federal Trade Commission and Department of Health and Human Services Feb. 14 requested comments for 60 days on market concentration and contracting…
Headline
The Department of Health and Human Services, Department of Justice, and Federal Trade Commission Dec. 7 announced several new actions to promote…
Headline
The companies that make the first 10 Medicare Part D drugs selected to participate in the Medicare Drug Price Negotiation Program have agreed to participate in…
Headline
The Food and Drug Administration will accept comments through Nov. 17 on draft guidance for labeling proposed biosimilar and interchangeable biosimilar…
Headline
A new Centers for Medicare & Medicaid Services fact sheet reviews how the agency selected the first 10 Part D drugs to include in the Medicare Drug Price…
Headline
The Department of Health and Human Services announced the first list of Medicare Part D drugs subject to price negotiations, a tenet of the Inflation…